Trial Profile
Multicenter Phase I/IIa Study to Assess the Safety and Efficacy of Expanded Allogenic Adipose-derived Stem Cells (eASCs) (Cx601), for Treatment of Complex Perianal Fistulas in Perianal Crohn's Disease.
Status:
Completed
Phase of Trial:
Phase I/II
Latest Information Update: 14 Apr 2022
Price :
$35
*
At a glance
- Drugs Darvadstrocel (Primary)
- Indications Rectal fistula
- Focus Adverse reactions
- Sponsors Cellerix; TiGenix
- 09 Apr 2022 This trial has been completed in spain, according to European Clinical Trials Database record (30 Sep 2010).
- 12 Feb 2015 Results were published in a TiGenix media release.
- 22 Sep 2014 New trial record